The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model

Cancer Immunology, Immunotherapy

Volumn 60, Issue 5, 2011, Pages 731-738

  Soto, Brenda L ^a   Hank, Jacquelyn A ^a,c   Van De Voort, Tyler J ^a   Subramanian, Lalita ^b   Polans, Arthur S ^b   Rakhmilevich, Alexander L ^a,c   Yang, Richard K ^a   Seo, Songwong ^c   Kim, Kyungmann ^a,c   Reisfeld, Ralph A ^d   Gillies, Stephen D ^e   Sondel, Paul M ^a,c,f  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e Provenance Biopharmaceuticals Corp   (United States)

^f University of Wisconsin Health   (United States)

Author keywords

Anti GD2 antibody; Hu14.18 IL2; Immunocytokine; Neuroblastoma; Resveratrol

Indexed keywords

CANCER VACCINE; CD45 ANTIGEN; HU14.18 INTERLEUKIN 2 IMMUNOCYTOKINE VACCINE; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD CELL COUNT; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MONOTHERAPY; MOUSE; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; TUMOR NECROSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD45; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; FLOW CYTOMETRY; GANGLIOSIDES; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INTERLEUKIN-2; LEUKOCYTES; MICE; MICE, INBRED A; NEOPLASM RECURRENCE, LOCAL; NEUROBLASTOMA; STILBENES; SURVIVAL; TUMOR BURDEN;

EID: 79955543330     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-0971-0     Document Type: Article

References (28)

1. PR van Ginkel D Sareen L Subramanian, et al. 2007 Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria Clin Cancer Res 13 5162 5169 17785572 10.1158/1078-0432.CCR-07- 0347 (Pubitemid 47502085)
2. Y Chen SH Tseng HS Lai WJ Chen 2004 Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice Surgery 136 57 66 15232540 10.1016/j.surg.2004.01.017 (Pubitemid 38834220)
3. S Busquets E Ametller G Fuster, et al. 2007 Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model Cancer Lett 245 144 148 16466851 10.1016/j.canlet.2005.12.035 1:CAS:528: DC%2BD2sXht1ehsQ%3D%3D (Pubitemid 44959346)
4. S Garvin K Ollinger C Dabrosin 2006 Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo Cancer Lett 23 113 122 10.1016/j.canlet.2005.01.031 (Pubitemid 41779459)
5. Y Kimura H Okuda 2001 Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice J Nutr 131 1844 1849 11385077 1:CAS:528:DC%2BD3MXkt12ksbg%3D (Pubitemid 32520456)
6. HS Liu CE Pan W Yang XM Liu 2003 Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice World J Gastroenterol 9 1474 1476 12854144 1:CAS:528:DC%2BD3sXoslajt7k%3D (Pubitemid 36992335)
7. ZC Neal JC Yang AL Rakhmilevich, et al. 2004 Enhanced activity of hu14.18-IL2 immunocytokine against murine NXS2 neuroblastoma when combined with interleukin 2 therapy Clin Cancer Res 10 4839 4847 15269160 10.1158/1078-0432. CCR-03-0799 1:CAS:528:DC%2BD2cXlvVegs7Y%3D (Pubitemid 38955538)
8. BH Yamane JA Hank MR Albertini PM Sondel 2009 The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma Expert Opin Investig Drugs 18 991 1000 19548853 10.1517/13543780903048911 1:CAS:528:DC%2BD1MXns1erur0%3D
9. C Laverdière Q Liu Y Yasui, et al. 2009 Long-term outcomes in survivors of neuroblastoma: a report from the childhood cancer survivor study J Natl Cancer Inst 101 1131 1140 19648511 10.1093/jnci/djp230
10. GJ Peters WJ van der Vijgh 1995 Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): preclinical aspects Eur J Cancer 31A Suppl 1 S1 S7 7577093 10.1016/0959-8049(95) 00145-9 1:CAS:528:DyaK2MXosF2gtrw%3D
11. T Siebler SM Shalet H Robson 2002 Effects of chemotherapy on bone metabolism and skeletal growth Horm Res 58 Suppl 1 80 85 12373019 10.1159/000064769 1:CAS:528:DC%2BD38XnslWqs7c%3D (Pubitemid 35316842)
12. JA Hank RR Robinson J Surfus, et al. 1990 Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant Interleukin-2 Cancer Res 50 5234 5239 2386933 1:CAS:528:DyaK3cXlslSitr0%3D (Pubitemid 20302968)
13. EE Johnson HD Lum AL Rakhmilevich, et al. 2008 Intratumoral immunocytokine treatment results in enhanced antitumor effects Cancer Immunol Immunother 57 1891 1902 18438664 10.1007/s00262-008-0519-0 1:CAS:528: DC%2BD1cXhtFCgu7jE
14. ZC Neal PM Sondel MK Bates SD Gillies H Herweijer 2007 Flt3-L gene therapy enhances immunocytokine-mediated antitumor effects and induces long-term memory Cancer Immunol Immunother 56 1765 1774 17426968 10.1007/s00262-007-0320- 5 1:CAS:528:DC%2BD2sXpsFehsLc%3D (Pubitemid 47313081)
15. MP Fuggetta S D'Atri G Lanzilli, et al. 2004 In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide Melanoma Res 14 189 196 15179187 10.1097/01.cmr.0000130007.54508.b2 1:CAS:528:DC%2BD2cXksF2ls7s%3D (Pubitemid 38879580)
16. T Kubota Y Uemura M Kobayashi H Taguchi 2003 Combined effects of resveratrol and paclitaxel on lung cancer cells Anticancer Res 23 4039 4046 14666716 1:CAS:528:DC%2BD2cXkvFKg (Pubitemid 37474362)
17. G Nicolini R Rigolio M Miloso AA Bertelli G Tredici 2001 Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line Neurosci Lett 302 41 44 11278107 10.1016/S0304-3940(01)01654-8 1:CAS:528:DC%2BD3MXitF2qsLg%3D (Pubitemid 32244192)
18. SL Wu ZJ Sun L Yu KW Meng XL Qin CE Pan 2004 Effect of resveratrol in combination with 5-FU on murine liver cancer Pharmacol Res 10 3048 3052 1:CAS:528:DC%2BD2cXptFSlt70%3D (Pubitemid 39303061)
19. P Boscolo A del Signore E Sabbioni, et al. 2003 Effects of resveratrol on lymphocyte proliferation and cytokine release Ann Clin Lab Sci 33 226 231 12817628 1:CAS:528:DC%2BD3sXlsFekt7k%3D (Pubitemid 36705934)
20. R Falchetti MP Fuggetta G Lanzilli M Tricarico G Ravagnan 2001 Effects of resveratrol on human immune cell function Life Sci 70 81 96 11764009 10.1016/S0024-3205(01)01367-4 1:CAS:528:DC%2BD3MXovVSjur4%3D (Pubitemid 33124357)
21. YH Feng WL Zhou QL Wu XY Li WM Zhao JP Zou 2002 Low dose of resveratrol enhanced immune response of mice Acta Pharmacol Sin 23 893 897 12370094 1:CAS:528:DC%2BD38XnvFGlu78%3D
22. X Gao D Deeb J Media, et al. 2003 Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects Biochem Pharamacol 66 2427 2435 10.1016/j.bcp.2003.08.008 1:CAS:528:DC%2BD3sXptVWmsbs%3D (Pubitemid 37456749)
23. Prophet EB, Mills B, Arrington JB, Sobin, LH Laboratory Methods in Histotechnology. Armed Froces Intitutes of Pathology, Washington, pp 53-55
24. E Dolfini L Roncoroni E Dogliotti, et al. 2007 Resveratrol impairs the formation of MDA-MB-231 multicellular tumor spheroids concomitant with ceramide accumulation Cancer Lett 249 143 147 16996206 10.1016/j.canlet.2006.08.013 1:CAS:528:DC%2BD2sXjsVektLk%3D (Pubitemid 46452922)
25. P Signorelli JM Munoz-Olaya V Gagliostro J Casas R Ghidoni G Fabriàs 2009 Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells Cancer Lett 282 238 243 19394759 10.1016/j.canlet.2009.03.020 1:CAS:528:DC%2BD1MXosVaisrc%3D
26. S Ulrich A Huwiler S Loitsch H Schmidt JM Stein 2007 De novo ceramide biosynthesis is associated with resveratrol-induced inhibition of ornithine decarboxylase activity Biochem Pharmacol 74 281 289 17521618 10.1016/j.bcp.2007.04.001 1:CAS:528:DC%2BD2sXmsFKgtLs%3D (Pubitemid 46890810)
27. F Minutolo G Sala A Bagnacani, et al. 2005 Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells J Med Chem 48 6783 6786 16250636 10.1021/jm050528k 1:CAS:528:DC%2BD2MXhtVGqtr3O (Pubitemid 41533099)
28. F Scarlatti G Sala C Ricci, et al. 2007 Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase Cancer Lett 253 124 130 17321671 10.1016/j.canlet.2007.01.014 1:CAS:528:DC%2BD2sXmtlWhsLw%3D (Pubitemid 46874732)